Combined Oral Contraceptive Use and Breast Cancer Risk: Select Considerations for Clinicians

被引:3
作者
Smrekar, Karly [1 ]
Lodise, Nicole M. [1 ]
机构
[1] Albany Coll Pharm & Hlth Sci, Pharm Practice, Albany, NY 12208 USA
关键词
birth control; breast cancer; combined oral contraceptives; contraceptive; estrogen; hormone; progestin; risk; women's health; HORMONAL CONTRACEPTION; WOMEN; PROGESTIN;
D O I
10.1016/j.nwh.2022.01.003
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Combined oral contraceptives (COCs) are commonly used by individuals for contraceptive and noncontraceptive purposes, such as the management of dysmenorrhea or to reduce risk for ovarian and endometrial cancer. However, a common consideration that continues to arise is whether COC use increases breast cancer risk. Many researchers have investigated this, but study results are varied and may be affected by variables such as hormone type, an individual's age, and the duration of COC use. In this article, we summarize select breast cancer risk considerations regarding COC use to assist clinicians when counseling individuals considering using oral contraceptives.
引用
收藏
页码:242 / 249
页数:8
相关论文
共 31 条
  • [1] Hormonal content and potency of oral contraceptives and breast cancer risk among young women
    Althuis, MD
    Brogan, DR
    Coates, RJ
    Daling, JR
    Gammon, MD
    Malone, KE
    Schoenberg, JB
    Brinton, LA
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (01) : 50 - 57
  • [2] American College of Obstetrics and Gynecology, 2017, Practice Bulletin, V179
  • [3] [Anonymous], 2012, PRINCIPLES EPIDEMIOL, Vthird
  • [4] [Anonymous], 2019, American cancer society recommendations for the early detection of breast cancer
  • [5] [Anonymous], 2020, Contraceptive Use in the United States
  • [6] Recent Oral Contraceptive Use by Formulation and Breast Cancer Risk among Women 20 to 49 Years of Age
    Beaber, Elisabeth F.
    Buist, Diana S. M.
    Barlow, William E.
    Malone, Kathleen E.
    Reed, Susan D.
    Li, Christopher I.
    [J]. CANCER RESEARCH, 2014, 74 (15) : 4078 - 4089
  • [7] Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study
    Busund, Marit
    Bugge, Nora S.
    Braaten, Tonje
    Waaseth, Marit
    Rylander, Charlotta
    Lund, Eiliv
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (11) : 2293 - 2302
  • [8] Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5
  • [9] Centers for Disease Control and Prevention, 2016, US Medical Eligibility Criteria for Contraceptive Use
  • [10] Centers for Disease Control and Prevention, 2020, What are the risk factors for breast cancer?